elinzanetant (NT-814) / Bayer 
Welcome,         Profile    Billing    Logout  
 8 Diseases   1 Trial   1 Trial   113 News 
9 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
elinzanetant (NT-814) / Bayer
OASIS-3, NCT05030584 / 2021-000059-38: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

Completed
3
628
Europe, Canada, US
Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms Associated With Menopause, Hot Flashes
03/23
02/24
OASIS-2, NCT05099159 / 2020-004855-34: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Completed
3
400
Europe, Canada, US, RoW
Elinzanetant (BAY3427080), Placebo
Bayer, Bayer Consumer Care AG
Vasomotor Symptoms Associated With Menopause, Hot Flashes
06/23
10/23
OASIS-1, NCT05042362 / 2020-004908-33: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Completed
3
396
Europe, US, RoW
Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms Associated With Menopause, Hot Flashes
07/23
11/23
2020-004855-34: A study to learn more about how well elinzanetant works and how safe it is for the treatment of vasomotor symptoms (hot flashes) that are caused by hormonal changes over 26 weeks in women who have been through the menopause

Not yet recruiting
3
370
Europe
BAY 3427080 SOFT CAPS 60 MG 001, BAY 3427080 (formerly NT-814), Capsule, soft
Bayer Consumer Care AG, Bayer Consumer Care AG
Vasomotor symptoms associated with menopause, Vasomotor symptoms associated with the menopause, a condition of having hot flashes that are caused by hormonal changes in women who have been through the menopause, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
OASIS-4, NCT05587296 / 2022-000095-18: A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Active, not recruiting
3
473
Europe, Canada, RoW
Elinzanetant (BAY3427080), Placebo
Bayer, Bayer Consumer Care AG, Bayer Consumer Care AG
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
01/24
12/26
2018-002763-26: NT-814 in menopausal females with vasomotor symptoms (SWITCH-1 study)

Not yet recruiting
2
165
Europe
NT-814, Capsule, soft
NeRRe Therapeutics Ltd,, KaNDy Therapeutics Ltd,
Hot flushes (vasomotor symptoms) in menopausal women, Hot flushes, Body processes [G] - Reproductive physiologi cal processes [G08]
 
 
NIRVANA, NCT06112756: A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause

Completed
2
110
Europe, US, RoW
Elinzanetant, Placebo
Bayer
Sleep Disturbances Associated With Menopause
08/24
11/24
NCT05481528: A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Completed
1
51
Europe
Moxifloxacin, Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers
02/23
04/23
NCT06219902: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Completed
1
64
Canada
Elinzanetant (BAY3427080), Placebo to elinzanetant, Zopiclone, Placebo to zopiclone
Bayer
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes
04/24
04/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
elinzanetant (NT-814) / Bayer
OASIS-3, NCT05030584 / 2021-000059-38: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

Completed
3
628
Europe, Canada, US
Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms Associated With Menopause, Hot Flashes
03/23
02/24
OASIS-2, NCT05099159 / 2020-004855-34: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Completed
3
400
Europe, Canada, US, RoW
Elinzanetant (BAY3427080), Placebo
Bayer, Bayer Consumer Care AG
Vasomotor Symptoms Associated With Menopause, Hot Flashes
06/23
10/23
OASIS-1, NCT05042362 / 2020-004908-33: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Completed
3
396
Europe, US, RoW
Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms Associated With Menopause, Hot Flashes
07/23
11/23
2020-004855-34: A study to learn more about how well elinzanetant works and how safe it is for the treatment of vasomotor symptoms (hot flashes) that are caused by hormonal changes over 26 weeks in women who have been through the menopause

Not yet recruiting
3
370
Europe
BAY 3427080 SOFT CAPS 60 MG 001, BAY 3427080 (formerly NT-814), Capsule, soft
Bayer Consumer Care AG, Bayer Consumer Care AG
Vasomotor symptoms associated with menopause, Vasomotor symptoms associated with the menopause, a condition of having hot flashes that are caused by hormonal changes in women who have been through the menopause, Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
OASIS-4, NCT05587296 / 2022-000095-18: A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Active, not recruiting
3
473
Europe, Canada, RoW
Elinzanetant (BAY3427080), Placebo
Bayer, Bayer Consumer Care AG, Bayer Consumer Care AG
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
01/24
12/26
2018-002763-26: NT-814 in menopausal females with vasomotor symptoms (SWITCH-1 study)

Not yet recruiting
2
165
Europe
NT-814, Capsule, soft
NeRRe Therapeutics Ltd,, KaNDy Therapeutics Ltd,
Hot flushes (vasomotor symptoms) in menopausal women, Hot flushes, Body processes [G] - Reproductive physiologi cal processes [G08]
 
 
NIRVANA, NCT06112756: A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause

Completed
2
110
Europe, US, RoW
Elinzanetant, Placebo
Bayer
Sleep Disturbances Associated With Menopause
08/24
11/24
NCT05481528: A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Completed
1
51
Europe
Moxifloxacin, Elinzanetant (BAY3427080), Placebo
Bayer
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers
02/23
04/23
NCT06219902: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Completed
1
64
Canada
Elinzanetant (BAY3427080), Placebo to elinzanetant, Zopiclone, Placebo to zopiclone
Bayer
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes
04/24
04/24

Download Options